infectious diseases society of america: Live & Latest News Updates : Vimarsana.com

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...

Mpox Cases Up in 2024: Is This Another Surge?

Although nowhere near the tens of thousands of cases seen in a 2022-23 outbreak, Mpox cases are up the first few months of 2024, compared to the same time last year. Here's what to know.

Do Our Flu Antivirals Work on H5N1?

Infectious disease physicians weigh in

Carbapenems Sometimes Overused for Drug-Resistant Enterobacterales Infections

Stewardship needs improving, experts say

Three Johns Hopkins Medicine Researchers Named Fellows of the American Association for the Advancement of Science

Three researchers from the Johns Hopkins University School of Medicine have been elected to the American Association for the Advancement of Science’s (AAAS) c

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

New antibiotics aren't being fully used, study finds

Is There a Vaccine for H5N1 Influenza?

And how quickly could it be deployed should it be needed?

Escondido school board trustee sworn in after winning special election